No Data
No Data
China International Capital Corporation: Can Hong Kong's mobile phone chain maintain stability and achieve unexpected feats in the era of Apple's AI?
In the era of edge AI, Apple enters the field of edge AI innovation, which is expected to drive interaction innovation, function upgrades/appearance changes, and closed-source ecology resonance. Android manufacturers may follow suit, and from 2H24 to 2025, Apple and Android industry chains may enjoy mutual prosperity. Hong Kong stock mobile phone chain is expected to deeply participate in the wave of innovation.
Express News | Bauing Construction Says Key Shareholder Zhuhai Da Heng Qin Plans to Offer 1.60 Yuan per Share to Raise Stake in Company to up to 51%
Gree Real Estate to Dispose of Assets to Buy 51% of Zhuhai Duty Free; Shares Up 6%
Gree Real Estate (SHA:600185) plans to acquire 51% of Zhuhai Duty Free Enterprise Group through the disposal of assets, according to the company's filing on the Shanghai Stock Exchange.The Chinese rea
GLE Announcements Selection: Zhuhai Guanyu Plans to Invest Not More Than 2 Billion Yuan in Malaysia Guanyu New Energy Project; Zijin Mining Group: Net Income Is Expected to Increase by About 41%-50% YoY in the First Half of the Year.
Investment project: Zhuhai Guanyu (688772.SH): plans to invest no more than 2 billion yuan to build new energy projects for Guanyu batteries in Malaysia; Tianyuan Group (002386.SZ): Haifeng and Rui plan to invest 0.136 billion yuan to build an optimized ion membrane electrolysis tank project for chlor-alkali plant; Tianyuan Group (002386.SZ): Haifeng and Tai plan to invest 73.8971 million yuan in the quality improvement optimization technology transformation project for titanium dioxide; Tianyuan Group (002386.SZ): Haifeng and Rui plan to invest 72.61 million yuan to build a 40MW/80WWh user-side electrochemical energy storage power station.
What SGSG Science&Technology Co., Ltd. Zhuhai's (SZSE:300561) 41% Share Price Gain Is Not Telling You
SGSG Science&Technology Co., Ltd. Zhuhai (SZSE:300561) shareholders would be excited to see that the share price has had a great month, posting a 41% gain and recovering from prior weakness. While
Zhuhai Rundu Pharmaceutical Gets Nod for Valsartan Hydrochlorothiazide Tablets
Zhuhai Rundu Pharmaceutical's (SHE:002923) valsartan hydrochlorothiazide tablets received a drug registration certificate from Chinese drug regulator National Medical Products Administration, accordin
No Data